We use cookies for a better user experience. Read our Privacy Policy
I Agree
Polymerase Chain Reaction (PCR) Consumables Market
The polymerase chain reaction (PCR) consumables market is expected to observe rapid growth owing to an increase in infectious diseases detection and novel developments in the forensic sciences sector. A rise in chronic diseases is also expected to fuel the growth of the polymerase chain reaction (PCR) consumables market) to a great extent.
With the COVID-19 infection rising extensively, the demand for polymerase chain reaction (PCR) consumables is extrapolated to attract substantial growth. The use of polymerase chain reaction consumables to detect the COVID-19 infection is increasing at a rapid rate. Hence, the growing use of polymerase chain reaction (PCR) consumables during the pandemic may serve as a growth booster for the polymerase chain reaction (PCR) consumables market across the globe.
As the demand for polymerase chain reaction consumables is increasing, the R&D activities in the global market are also gaining traction. )The adoption of novel technologies are possible through these activities, which increase the convenience quotient among the consumers, eventually attracting a large customer base. Hence, these aspects eventually increase the growth rate of the polymerase chain reaction (PCR) consumables market. Companies are also indulging in different strategies such as mergers, acquisitions, joint ventures, and partnerships in order to expand their businesses in the polymerase chain reaction (PCR) consumables market in newer regions.
The competitive landscape of the polymerase chain reaction (PCR) consumables market is fragmented. The rising prevalence of cancer around the world is expected to serve as a growth propelling factor in the polymerase chain reaction (PCR) consumables market. PCR consumables assist in the identification of genomic differences to predict drug resistance. These predictions can be used for tailoring a treatment according to the specific cancer type. Furthermore, increased funding from various government and non-government organizations in the biotechnology sector will prove to be a growth booster for the polymerase chain reaction (PCR) consumables market.
Polymerase Chain Reaction (PCR) Consumables Market - Snapshot
Polymerase chain reaction (PCR) is used to amplify or make many copies of a deoxyribonucleic acid (DNA) sequence of interest. It is used in a variety of applications such as DNA cloning, diagnosis of hereditary diseases, functional analysis of genes, paternity testing, detection of infectious diseases, and forensic sciences. The global polymerase chain reaction (PCR) consumables market was valued at around US$ 415.20 Mn in 2017 and is anticipated to expand at a CAGR of more than 4.5% from 2018 to 2026 to reach around US$ 639.89 Mn by 2026. Rise in geriatric population, increasing adoption of personalized medicine, rise in the incidence of chronic diseases, and growing awareness about disease diagnosis are some of the factors that are accelerating the growth of the polymerase chain reaction (PCR) consumables market.
Over a period of time, applications of PCR consumables have increased rapidly in the areas of life sciences, health care, clinical research, pharmaceuticals, and food & beverage. Technological advancements have been made to meet specific requirements for the amplification of desired biological components from the sample solutions and to improve overall throughput time and work efficiency of laboratories. Developments in the molecular diagnostic technology, fueled by the need for fast, accurate diagnosis for patients and doctors in the ever-evolving health care industry, are boosting the polymerase chain reaction (PCR) consumables market. Identification of genomic differences to predict drug resistance or drug response by patients could offer scope to design a therapy tailored to the specific characteristics of a particular type of cancer. The understanding and exploration of cancer cells through PCR technology is expected to help in developing targeted therapy and personalized, preventive, and therapeutic solutions for different types of cancer. According to the WHO, approximately 35.3 million people were diagnosed with HIV and approximately 1.6 million people died of AIDS in 2012. Moreover, according to the Centers for Disease Control and Prevention (CDC), approximately 50,000 individuals are diagnosed with HIV in the U.S. each year. PCR has enabled the identification of pathogens within a short span of time and has played a pivotal role in the management of various chronic viral infections.
The polymerase chain reaction (PCR) consumables market has been segmented based on product, distribution channel, and region. In terms of product, the PCR tubes segment is estimated to account for a large share of the market. PCR has transformed disciplines from forensics to food safety and clinical diagnostics to genomics in the last two decades. There is potential for future development of the technology. R&D would boost market expansion and create new avenues for revenue generation, as was demonstrated in the past with qPCR. One of the newest developments in the use of PCR technology in molecular diagnostics is the polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA), an advanced immune-detection method.
Based on distribution channel, the research and academic institutes segment constituted a major share of the market in 2017. The segment is likely to expand at a considerable growth rate as compared to other distribution channel segments during the forecast period. The polymerase chain reaction (PCR) consumables market has expanded at a rapid pace in the past few years, mainly due to increasing participation of public research organizations. Rise in government and private funding for research and investments in R&D by biotechnology companies is expected to drive the research and academic institutes segment.
In terms of region, the global polymerase chain reaction (PCR) consumables market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Developed regions such as North America and Europe accounted for a leading share of the global polymerase chain reaction (PCR) consumables market in 2017. The large base of biopharmaceutical companies and research and academic institutes in these regions has contributed to the leading share of these regions. Moreover, rapid expansion and increase in number of research and academic institutes in these regions are expected to propel demand for polymerase chain reaction (PCR) consumables during the forecast period. The market in Asia Pacific is projected to expand at an exponential growth rate, owing rapidly improving health care facilities in countries such as India, China, South Korea, and Malaysia. Japan dominated the polymerase chain reaction (PCR) consumables market in Asia Pacific, whereas the market in China is anticipated to record significant growth during the forecast period. Also, increase in investment by leading clinical diagnostic labs and hospitals providers is expected to fuel the market in the region. These factors are likely to drive demand for polymerase chain reaction (PCR) consumables in the near future. The market in Latin America and Middle East & Africa is projected to maintain a steady growth rate during the forecast period.
Prominent players in the global polymerase chain reaction (PCR) consumables market include Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd., Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Merck KGaA, Agilent Technologies, Inc., Eppendorf Group, 4titude, Corning Incorporated, and Greiner Bio-One International GmbH.
The global polymerase chain reaction (PCR) consumables market has been segmented as follows:
|
Product |
|
|
End-user |
|
|
Geography |
|
Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology
Section 3 Executive Summary
3.1 Global Polymerase Chain Reaction (PCR) Consumables Market Snapshot
3.2 Market Share Analysis by Region, 2017
Section 4 Market Overview
4.1 Polymerase Chain Reaction (PCR) Consumables Market Taxonomy
4.2 Global Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, 2016–2026
4.3 Global Polymerase Chain Reaction (PCR) Consumables Market: Market Outlook
Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Key Trends
5.6 Porter’s Five Forces Analysis for the Global PCR Market
5.7 Overview of Polymerase Chain Reaction (PCR)
5.8 Polymerase Chain Reaction Techniques
Section 6 Polymerase Chain Reaction (PCR) Consumables Market Analysis, by Product
6.1 Introduction
6.2 Global Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Product
6.3 Polymerase Chain Reaction (PCR) Consumables Market Forecast, by Product
6.3.1 PCR Tubes
6.3.2 PCR Microplates
6.3.3 Caps/Lids
6.3.4 Others
6.4 Market Attractiveness Analysis, by Product
Section 7 Polymerase Chain Reaction (PCR) Consumables Market Analysis, by End-user
7.1 Introduction
7.2 Global Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by End-user
7.3 Polymerase Chain Reaction (PCR) Consumables Market Forecast, by End-user
7.3.1 Research and Academic Institutes
7.3.2 Clinical Diagnostic Labs and Hospitals
7.3.3 Pharmaceutical and Biotechnology Companies
7.3.4 Others
7.4 Market Attractiveness Analysis, by End-user
Section 8 Polymerase Chain Reaction (PCR) Consumables Market Analysis, by Region
8.1 Global Polymerase Chain Reaction (PCR) Consumables Market, Global Market Scenario
8.2 Global Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Region
8.3 Polymerase Chain Reaction (PCR) Consumables Market Forecast, by Region
8.4 Market Attractiveness Analysis, by Region
Section 9 North America Polymerase Chain Reaction (PCR) Consumables Market Analysis
9.1 Market Overview
9.2 Market Analysis, by Product
9.2.1 Market Value Share Analysis, by Product
9.2.2 Market Size (US$ Mn) Forecast, by Product
9.2.2.1 PCR Tubes
9.2.2.2 PCR Microplates
9.2.2.3 Caps/Lids
9.2.2.4 Others
9.3 Market Analysis, by End-user
9.3.1 Market Value Share Analysis, by End-user
9.3.2 Market Size (US$ Mn) Forecast, by End-user
9.3.2.1 Research and Academic Institutes
9.3.2.2 Clinical Diagnostic Labs and Hospitals
9.3.2.3 Pharmaceutical and Biotechnology Companies
9.3.2.4 Others
9.4 Market Analysis, by Country
9.4.1 Market Value Share Analysis, by Country
9.4.2 Market Size (US$ Mn) Forecast, by Country, 2018–2026
9.4.2.1 U.S.
9.4.2.2 Canada
9.5 Market Attractiveness Analysis
9.5.1 by Country
9.5.2 by Product
9.5.3 by End-user
Section 10 Europe Polymerase Chain Reaction (PCR) Consumables Market Analysis
10.1 Market Overview
10.2 Market Analysis, by Product
10.2.1 Market Value Share Analysis, by Product
10.2.2 Market Size (US$ Mn) Forecast, by Product
10.2.2.1 PCR Tubes
10.2.2.2 PCR Microplates
10.2.2.3 Caps/Lids
10.2.2.4 Others
10.3 Market Analysis, by End-user
10.3.1 Market Value Share Analysis, by End-user
10.3.2 Market Size (US$ Mn) Forecast, by End-user
10.3.2.1 Research and Academic Institutes
10.3.2.2 Clinical Diagnostic Labs and Hospitals
10.3.2.3 Pharmaceutical and Biotechnology Companies
10.3.2.4 Others
10.4 Market Analysis, by Country
10.4.1 Market Value Share Analysis, by Country
10.4.2 Market Size (US$ Mn) Forecast, by Country, 2018–2026
10.4.2.1 U.K.
10.4.2.2 Germany
10.4.2.3 France
10.4.2.4 Spain
10.4.2.5 Italy
10.4.2.6 Rest of Europe
10.5 Market Attractiveness Analysis
10.5.1 by Country
10.5.2 by Product
10.5.3 by End-user
Section 11 Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Analysis
11.1 Market Overview
11.2 Market Analysis, by Product
11.2.1 Market Value Share Analysis, by Product
11.2.2 Market Size (US$ Mn) Forecast, by Product
11.2.2.1 PCR Tubes
11.2.2.2 PCR Microplates
11.2.2.3 Caps/Lids
11.2.2.4 Others
11.3 Market Analysis, by End-user
11.3.1 Market Value Share Analysis, by End-user
11.3.2 Market Size (US$ Mn) Forecast, by End-user
11.3.2.1 Research and Academic Institutes
11.3.2.2 Clinical Diagnostic Labs and Hospitals
11.3.2.3 Pharmaceutical and Biotechnology Companies
11.3.2.4 Others
11.4 Market Analysis, by Country
11.4.1 Market Value Share Analysis, by Country
11.4.2 Market Size (US$ Mn) Forecast, by Country, 2018–2026
11.4.2.1 China
11.4.2.2 Japan
11.4.2.3 India
11.4.2.4 Australia & New Zealand
11.4.2.5 Rest of Asia Pacific
11.5 Market Attractiveness Analysis
11.5.1 by Country
11.5.2 by Product
11.5.3 by End-user
Section 12 Latin America Polymerase Chain Reaction (PCR) Consumables Market Analysis
12.1 Market Overview
12.2 Market Analysis, by Product
12.2.1 Market Value Share Analysis, by Product
12.2.2 Market Size (US$ Mn) Forecast, by Product
12.2.2.1 PCR Tubes
12.2.2.2 PCR Microplates
12.2.2.3 Caps/Lids
12.2.2.4 Others
12.3 Market Analysis, by End-user
12.3.1 Market Value Share Analysis, by End-user
12.3.2 Market Size (US$ Mn) Forecast, by End-user
12.3.2.1 Research and Academic Institutes
12.3.2.2 Clinical Diagnostic Labs and Hospitals
12.3.2.3 Pharmaceutical and Biotechnology Companies
12.3.2.4 Others
12.4 Market Analysis, by Country
12.4.1 Market Value Share Analysis, by Country
12.4.2 Market Size (US$ Mn) Forecast, by Country, 2018–2026
12.4.2.1 Brazil
12.4.2.2 Mexico
12.4.2.3 Rest of Latin America
12.5 Market Attractiveness Analysis
12.5.1 by Country
12.5.2 by Product
12.5.3 by End-user
Section 13 Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Analysis
13.1 Market Overview
13.2 Market Analysis, by Product
13.2.1 Market Value Share Analysis, by Product
13.2.2 Market Size (US$ Mn) Forecast, by Product
13.2.2.1 PCR Tubes
13.2.2.2 PCR Microplates
13.2.2.3 Caps/Lids
13.2.2.4 Others
13.3 Market Analysis, by End-user
13.3.1 Market Value Share Analysis, by End-user
13.3.2 Market Size (US$ Mn) Forecast, by End-user
13.3.2.1 Research and Academic Institutes
13.3.2.2 Clinical Diagnostic Labs and Hospitals
13.3.2.3 Pharmaceutical and Biotechnology Companies
13.3.2.4 Others
13.4 Market Analysis, by Country
13.4.1 Market Value Share Analysis, by Country
13.4.2 Market Size (US$ Mn) Forecast, by Country, 2018–2026
13.4.2.1 South Africa
13.4.2.2 GCC
13.4.2.3 Israel
13.4.2.4 Rest of Middle East & Africa
13.5 Market Attractiveness Analysis
13.5.1 by Country
13.5.2 by Product
13.5.3 by End-user
Section 14 Company Profiles
14.1 Global Polymerase Chain Reaction (PCR) Consumables Market Position Analysis, by Company
14.2 Competition Matrix
14.3 Company Profiles
14.3.1 Bio-Rad Laboratories, Inc.
14.3.1.1 Company Overview
14.3.1.2 Financial Overview
14.3.1.3 Product Portfolio
14.3.1.4 SWOT Analysis
14.3.1.5 Strategic Overview
14.3.2 F. Hoffmann-La Roche Ltd.
14.3.2.1 Company Overview
14.3.2.2 Financial Overview
14.3.2.3 Product Portfolio
14.3.2.4 SWOT Analysis
14.3.2.5 Strategic Overview
14.3.3 Thermo Fisher Scientific Inc.
14.3.3.1 Company Overview
14.3.3.2 Financial Overview
14.3.3.3 Product Portfolio
14.3.3.4 SWOT Analysis
14.3.3.5 Strategic Overview
14.3.4 Qiagen N.V.
14.3.4.1 Company Overview
14.3.4.2 Financial Overview
14.3.4.3 Product Portfolio
14.3.4.4 SWOT Analysis
14.3.4.5 Strategic Overview
14.3.5 Merck KGaA
14.3.5.1 Company Overview
14.3.5.2 Financial Overview
14.3.5.3 Product Portfolio
14.3.5.4 SWOT Analysis
14.3.5.5 Strategic Overview
14.3.6 Agilent Technologies, Inc.
14.3.6.1 Company Overview
14.3.6.2 Financial Overview
14.3.6.3 Product Portfolio
14.3.6.4 SWOT Analysis
14.3.6.5 Strategic Overview
14.3.7 Eppendorf Group
14.3.7.1 Company Overview
14.3.7.2 Financial Overview
14.3.7.3 Product Portfolio
14.3.7.4 SWOT Analysis
14.3.7.5 Strategic Overview
14.3.8 4titude
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.8.4 Strategic Overview
14.3.9 Corning Incorporated
14.3.9.1 Company Overview
14.3.9.2 Financial Overview
14.3.9.3 Product Portfolio
14.3.9.4 SWOT Analysis
14.3.9.5 Strategic Overview
14.3.10 Greiner Bio-One International GmbH
14.3.10.1 Company Overview
14.3.10.2 Financial Overview
14.3.10.3 Product Portfolio
14.3.10.4 SWOT Analysis
14.3.10.5 Strategic Overview
List of Tables
Table 01: Global Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 03: Global Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 04: North America Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 05: North America Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 06: Europe Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 07: Europe Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 08: Europe Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 09: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 10: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Latin America Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 13: Latin America Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 14: Latin America Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 15: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 16: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 17: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
List of Figures
Figure 01: Global Polymerase Chain Reaction (PCR) Consumables Market Snapshot
Figure 02: Global Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 03: Market Value Share By Product (2017)
Figure 04: Market Value Share By End-user (2017)
Figure 05: Market Value Share By Region (2017)
Figure 06: Global Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Product, 2017 and 2026
Figure 07: PCR Tubes Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2026
Figure 08: PCR Microplates Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2026
Figure 09: Caps/Lids Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2026
Figure 10: Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2026
Figure 11: Global Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Product
Figure 12: Global Polymerase Chain Reaction (PCR) Consumables Market Value Share, by End-user, 2017 and 2026
Figure 13: Research and Academic Institutes Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 14: Clinical Diagnostic Labs and Hospitals Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 15: Pharmaceutical and Biotechnology Companies Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 16: Others Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 17: Global Polymerase Chain Reaction (PCR) Consumables Market Attractiveness, by End-user
Figure 18: Global Polymerase Chain Reaction (PCR) Consumables Market Value Share, by Region, 2017 and 2026
Figure 19: Global Polymerase Chain Reaction (PCR) Consumables Market Attractiveness, by Region
Figure 20: North America Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, 2016–2026
Figure 21: North America Market Attractiveness Analysis, by Country
Figure 22: North America Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis by Product Type, 2017 and 2026
Figure 23: North America Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis by End-user, 2017 and 2026
Figure 24: North America Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Country, 2017 and 2026
Figure 25: North America Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Product
Figure 26: North America Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by End-user
Figure 27: Europe Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, 2016–2026
Figure 28: Europe Polymerase Chain Reaction (PCR) Consumables Market Attractiveness, by Country/Sub-region
Figure 29: Europe Polymerase Chain Reaction (PCR) Consumables Market Value Share, by Product, 2017 and 2026
Figure 30: Europe Polymerase Chain Reaction (PCR) Consumables Market Value Share, by End-user, 2017 and 2026
Figure 31: Europe Polymerase Chain Reaction (PCR) Consumables Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 32: Europe Polymerase Chain Reaction (PCR) Consumables Market Attractiveness, by Product
Figure 33: Europe Polymerase Chain Reaction (PCR) Consumables Market Attractiveness, by End-user
Figure 34: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 35: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 36: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Value Share, by Product, 2017 and 2026
Figure 37: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Value Share, by End-user, 2017 and 2026
Figure 38: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 39: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Attractiveness, by Product, 2018–2026
Figure 40: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Attractiveness, by End-user, 2018–2026
Figure 41: Latin America Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 42: Latin America Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
Figure 43: Latin America Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Product, 2017 and 2026
Figure 44: Latin America Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis by End-user, 2017 and 2026
Figure 45: Latin America Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 46: Latin America Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Product
Figure 47: Latin America Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Application
Figure 48: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Size (US$ Mn) Forecast, 2016–2026
Figure 49: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Attractiveness, by Country/Sub-region
Figure 50: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Value Share, by Product, 2017 and 2026
Figure 51: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Value Share, by End-user, 2017 and 2026
Figure 52: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 53: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Attractiveness, by Product
Figure 54: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Attractiveness, by End-user
Figure 55: Global Polymerase Chain Reaction (PCR) Consumables Market Analysis, by Top Company Ranking, 2017
Figure 56: Bio-Rad Laboratories, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
Figure 57: Bio-Rad Laboratories, Inc. Breakdown of Net Sales (% Share), by Business Segment (2017)
Figure 58: Bio-Rad Laboratories, Inc. R&D Intensity and Sales & Marketing Intensity (US$ Mn), 2015–2017
Figure 59: Bio-Rad Laboratories, Inc. Breakdown of Net Sales (% Share), by Region (2017)
Figure 60: F. Hoffmann-La Roche Ltd. Revenue (US$ Bn) and Y-o-Y Growth (%), by Diagnostics 2014–2017
Figure 61: F. Hoffmann-La Roche Ltd. Breakdown of Diagnostics Net Sales, by Region, 2017
Figure 62: F. Hoffmann-La Roche Ltd. R&D and Sales & Distribution Spending, by Diagnostics, (US$ Mn), 2016–2017
Figure 63: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales, by Diagnostic Business Segment, 2017
Figure 64: Thermo Fisher Scientific Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2017
Figure 65: Thermo Fisher Scientific Inc. Breakdown of Net Sales, by Business Segment, 2017
Figure 66: Thermo Fisher Scientific Inc. R&D and Selling, general and administrative expenses, by Diagnostics, (US$ Mn), 2015–2017
Figure 67: Thermo Fisher Scientific Inc. Breakdown of Net Sales, by Region, 2017
Figure 68: Qiagen N.V. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2017
Figure 69: Qiagen N.V. Breakdown of Net Sales, by Business Segment, 2017
Figure 70: Qiagen N.V. R&D and Selling, General, and Administrative Expenses, by Diagnostics, (US$ Mn), 2015–2017
Figure 71: Qiagen N.V. Breakdown of Net Sales, by Region, 2017
Figure 72: Merck KGaA Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 73: Merck KGaA Breakdown of Net Sales, by Business Segment, 2017
Figure 74: Merck KGaA R&D and Selling, General, and Administrative Expenses, by Diagnostics, (US$ Mn), 2016–2017
Figure 75: Merck KGaA Breakdown of Net Sales, by Region, 2017
Figure 76: Agilent Technologies, Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2015–2017
Figure 77: Agilent Technologies, Inc. Breakdown of Net Sales, by End-user, 2017
Figure 78: Agilent Technologies, Inc. R&D and Selling, General and Administrative Expenses, by Diagnostics, (US$ Mn), 2015–2017
Figure 79: Agilent Technologies, Inc. Breakdown of Net Sales, by Region, 2017
Figure 80: Eppendorf Group Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
Figure 81: Eppendorf Group Breakdown of Employees, by Region, 2017
Figure 82: Eppendorf Group R&D and Selling, General and Administrative Expenses, by Diagnostics, (US$ Mn), 2015–2017
Figure 83: Eppendorf Group Breakdown of Net Sales, by Region, 2017
Figure 84: Corning Incorporated Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
Figure 85: Corning Incorporated Breakdown of Net Sales, by Business Segment, 2017
Figure 86: Corning Incorporated R&D and Selling, General and Administrative Expenses, by Diagnostics, (US$ Mn), 2016–2017
Figure 87: Corning Incorporated Breakdown of Net Sales, by Region, 2017
Figure 88: Greiner Bio-One International GmbH Revenue (US$ Mn) & Y-o-Y Growth (%) of Greiner Group, 2015–2017
Figure 89: Greiner Bio-One International GmbH Breakdown of Net Sales of Greiner Group, by Subsidiary, 2017
Figure 90: Greiner Bio-One International GmbH Revenue (US$ Mn) & Y-o-Y Growth (%) of Greiner Bio-One International GmbH, 2015–2017
Figure 91: Greiner Bio-One International GmbH Breakdown of Net Sales of Greiner Group, by Region, 2017
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes